Trial Information

Summary: Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Vaccine

Intranasal Vaccine Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3), in Healthy 6 to <24 Month-Old Children and in 2 Month Old Infants - Minors. Parents/ guardians of children 6 to less than 24 month-old or 2 month old Infants are asked to participate in a research study for a vaccine against RSV or PIV3 being conducted by Jacobi Medical Center.

Your child may be eligible to participate in this study if he/she:

• Is 2 months old
• Is 6 months of age or older but have not yet reached their 2nd year birthday
• Is in general good health and normal growth

Your child may not participate in this study if he/she:

• Has a fever or other respiratory illness
• Has moderate or severe nasal congestion
• Has received any drug therapy within 7 days
• Will or is receiving immunosuppressive agents including steroids
• Has had or will have a blood transfusion within 28 days
• Has received any live virus vaccine (excluding rotavirus vaccine) within 28 days
• Has a known or suspected immunodeficiency, including HIV infection
• Is expected to be living in the same home or enrolled in the same classroom at day care with infants <6 months within 28 days after each dose
• Has known or suspected active or chronic hepatitis infection
• Has a history of medical diagnosis of asthma, reactive airway disease, wheezing requiring medication, cystic fibrosis, bronchopulmonary dysplasia, chronic pulmonary disease, medically confirmed apnea, hospitalization for respiratory illness or mechanical ventilation
• Has participated in another research study within the last 60 days

If you would like to learn more about participating in this study, please send an e-mail message using the form below.